Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
794.00    4.00 (0.51%)
Bid:
774.00
Ask:
780.00
Spread: 6.00 (0.775%)
Market Cap: £366.00m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

AGM/Interim Management Statement

13 Apr 2010 07:00

RNS Number : 0520K
Porvair PLC
13 April 2010
 



FOR IMMEDIATE RELEASE

13 April 2010

 

Porvair plc

AGM Statement and Interim Management Statement

 

Porvair plc ("Porvair"), the specialist filtration and environmental technology group will today, 13 April 2010, make the following Interim Management Statement at its Annual General Meeting:

 

Porvair has made an encouraging start to the 2010 financial year. In the four months to 31 March 2010, profit before tax is well ahead of the prior year. Current net borrowings are £3.3m lower than the equivalent time last year. At constant exchange rates, revenues are around 5% higher than the prior period, with recovery or continued growth in most markets offset by expected modest declines in aerospace filtration sales.

 

In the Metals Filtration division sales revenues are 13% higher than the prior period. This business has a lower cost base following its 2009 restructuring and as a result profitability is better. It should be noted that whilst levels of demand in 2010 have improved, they remain below those of 2004-2008 and management continue to look at projects that will boost the underlying performance of this division. Key to this will be the sustained success of new products, which continue to go well. 85% of the division's aluminium customers have now converted to the patented Selee CS-X™ filter. Upgrades have been introduced in recent weeks that further enhance this market leading product in the aluminium industry. In the iron foundry industry, a similarly exciting new product, the patented Selee IC™ filter, has now been adopted by several leading automotive and agricultural machinery manufacturers in the US.

 

In the Microfiltration division sales revenues are slightly ahead of the prior year. Seal Analytical has made a strong start with improved sales in the US and Europe and continuing strength in Asia helped by the introduction of the Seal Analytical AQ1™ water analyser in February 2010. The division is seeing satisfactory levels of demand in energy and nuclear filtration where several larger orders are scheduled for delivery later in the year. Growth in this division's US industrial filtration business has been robust. This is offset by a decline in aerospace schedules compared with a strong opening quarter of the prior year. Aerospace sales in 2010 are at similar levels to the second half of 2009 with run rates and order schedules showing modest improvements over the last three months.

 

The Company will be announcing its interim results for the six months ending 31 May 2010 on Tuesday 29 June 2010.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Catherine Breen

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSFLFLEFSSEDL
Date   Source Headline
11th Nov 20201:17 pmRNSHolding(s) in Company
9th Nov 20207:00 amRNSDirectorate Change
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20204:35 pmRNSPrice Monitoring Extension
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSNine months trading update
18th Sep 20203:58 pmRNSChange of auditor
2nd Sep 20202:09 pmRNSHolding(s) in Company
19th Aug 20204:03 pmRNSDirector/PDMR Shareholding
10th Aug 20204:40 pmRNSSecond Price Monitoring Extn
10th Aug 20204:36 pmRNSPrice Monitoring Extension
31st Jul 20207:00 amRNSTotal Voting Rights
3rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20207:00 amRNSHalf Year Results 2020
25th Jun 20204:52 pmRNSDirector/PDMR Shareholding
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
20th May 20204:36 pmRNSPrice Monitoring Extension
19th May 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20209:27 amRNSPublication of Articles of Association
21st Apr 20201:59 pmRNSAGM resolutions and Board changes
8th Apr 20204:03 pmRNSBlock listing six monthly return
8th Apr 20207:00 amRNSTrading Update and Covid-19 Statement
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn
26th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSAnnual General Meeting 2020 – Change of Venue
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 202012:08 pmRNSSecond Price Monitoring Extn
18th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202010:20 amRNSHolding(s) in Company
18th Feb 202012:07 pmRNSSecond Price Monitoring Extn
18th Feb 202012:02 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSDirector/PDMR Shareholding
11th Feb 20203:15 pmRNSPDMR Shareholding Grant of Options
3rd Feb 20207:00 amRNSPreliminary Results and Board Changes
18th Dec 20195:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.